DOVE Economic Benefits Model

Did you know that the models developed by the DOVE project estimate the costs averted by vaccination? The models focuses on ten antigens and 94 low- and middle-income countries, 2001-2030. Results are used at the global and regional level to advocate for new vaccine introduction and increased coverage.

You can read about the application of the DOVE-COI models in the linked publication.

Ozawa S, Clark S, Portnoy A, Grewal S, Stack M, Sinha A, Mirelman A, Franklin H, Friberg I, Tam Y, Walker N, Clark A, Ferrari M, Suraratdecha C, Sweet S, Goldie S, Garske T, Li M, Hansen P, Johnson H, Walker D. Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2030. Bulletin of the World Health Organization 2017; 95: 629-638.

Read article

LanguageEnglish

Submit your work

Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.

Submit your work